← 返回

Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.

Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.

期刊: Cardiac electrophysiology clinics 日期: 2026-09-01 PMID: 42580797 DOI: 10.1016/j.ccep.2026.06.010 浏览: 13
作者: Sreedhara K, Panjrath G
K, S. & G, P. (2026). Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.. Cardiac electrophysiology clinics. https://doi.org/10.1016/j.ccep.2026.06.010
K S, G P. Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.. Cardiac electrophysiology clinics. 2026; doi: 10.1016/j.ccep.2026.06.010
K S, G P. Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.[J]. Cardiac electrophysiology clinics. 2026. DOI: 10.1016/j.ccep.2026.06.010.
@article{k2026,
  author = {Sreedhara K and Panjrath G},
  title = {Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.},
  journal = {Cardiac electrophysiology clinics},
  year = {2026},
  doi = {10.1016/j.ccep.2026.06.010},
  note = {PMID: 42580797},
}
TY  - JOUR
AU  - Sreedhara K
AU  - Panjrath G
TI  - Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction.
T2  - Cardiac electrophysiology clinics
PY  - 2026
DO  - 10.1016/j.ccep.2026.06.010
AN  - PMID:42580797
ER  - 

摘要

Advanced heart failure is characterized by persistent severe symptoms and functional limitations despite optimal medical therapy and carries significant morbidity and mortality. This article discusses the key parameters of this clinical syndrome that should prompt referral by primary care providers and general cardiologists to advanced heart failure and transplantation centers, which is paramount to improving the quality of life and survival of these patients. It also aims to elucidate the evaluation process for determining candidacy for advanced therapies, including key indications and contraindications to left ventricular assist device implantation and heart transplantation.

AI 智能解读

相关文献

返回分类: 心衰 查看原文 (DOI)
已选择 0 篇文献